President's Message
Dear Colleagues,
Can you believe the year is almost over? 2013 has been a great year for SITC, and on behalf of the Society, I would like to thank everyone who has volunteered and dedicated their time to SITC and helped make this year a success! I would especially like to thank everyone who participated in the SITC 28th Annual Meeting & Associated Programs. More than 1,100 people from 32 different countries attended SITC 2013, making it the largest meeting in SITC history! The meeting set a new abstract submission record and a record number of exhibitors as well.
Feedback received from the meeting included:
- "The SITC 2013 meeting was a big success not only because of the number of registered attendees, but thanks to the quality of the speakers and the relevance of the program put together by the meeting organizers. Each session, including the very last one, was fully packed, which is quite unusual in my experience with large oncology meetings.”
- Alessandra Cesano, MD, PhD - Nodality, Inc.
- “The SITC meeting presented an extensive amount of high quality basic and applied research in the tumor immunotherapy field. Because of this, it is becoming the most innovative and important immunotherapy congress world-wide.”
- Paulo C. Rodriguez, PhD - LSUHSC - Stanley S. Scott Cancer Center
- "One of the best parts of this job is traveling to conferences such as SITC to get new ideas, meet new people, and get re-energized to make an impact... At SITC 2013 I was able to solidify a new collaboration and the samples arrive to my lab next week!”
- Charlie Garnett Benson, PhD - Georgia State University
While the year is coming to an end, SITC still has many upcoming, exciting educational opportunities around the world. Please take a moment to review this email to find out more and be on the lookout for more information on additional SITC programs to come soon.
Happy Holidays!
.jpg){kind=small}
Francesco M. Marincola, MD
SITC President
Coming Soon!
SITC 28th Annual Meeting & Associated Programs Presentations
Those who registered for SITC 2013 will be able to view presentations from the programs they registered for within the next few weeks! An email will go out once presentations are ready, so please be on the lookout! If you were unable to attend SITC 2013, you will be able to purchase access to presentations at that time as well.
Limited space remains for SITC's regional, CME- certified
"Advances in Cancer Immunotherapy" Programs Near YOU
 |
Onsite registration is available for these programs which are specifically designed for clinical oncologists and the entire unit of care involved in treating cancer patients with immunotherapy. Each program will feature local expert speakers, and the opportunity for professional networking to form collaborations and promote scientific exchange. For more information, please visit: www.sitcancer.org/sitc-meetings/aci2013.
Register Now for "Updates on Immunotherapy of Cancer and Immunoscore"
Part of the Sidra Symposia Series, Held in Partnership with the Society for Immunotherapy of Cancer
.jpg)
January 22-23, 2014 • Four Seasons Doha • Doha, Qatar
(Please note location change)
This symposium is focused on improving the outcome for patients with cancer by incorporating strategies based on cancer immunotherapy. With leading authorities in tumor immunology and cancer immunotherapy, this program will describe the latest research advances, focus on currently approved and emerging tumor immunotherapy approaches and provide highlights on SITC initiatives and projects including the Immunoscore. For more information please visit the official Sidra Symposium website at: www.sidrasitcqatar2014.com.
Melanoma Bridge 2013 Begins This Week!
December 5-8, 2013 • Royal Continental Hotel • Naples, Italy
Melanoma Bridge 2013 aims to achieve a broad-based participation by various groups and societies sharing a clinical or basic interest in the immunology and biology of the cancer microenvironment.
The meeting will consist of the following sections: diagnosis and new procedures, molecular advances and combination therapies, news in immunotherapy, tumor microenvironment and biomarkers, world-wide SITC Immunoscore Task Force update and round table of US and EU Regulatory Agency on melanoma drugs. For more information visit: www.sitcancer.org/sitc-meetings/melanoma-bridge-2013.
First European Immunotherapy of Cancer Conference, Coming in 2014
March 12-14, 2014 • Munich, Germany
The program will focus on topics such as immunomodulatory agents, anti-cancer vaccines and monoclonal antibodies with special emphasis on translational research and biomarker development, with the goal of providing a forum for discussion on early clinical drug development and address the unique challenges involved. Organized by the Biotherapy Development Association (BDA), partners include SITC, Comprehensive Cancer Center of the Ludwig-Maximilians-Universitat Munchen (CCCLMU), Roman-Herzog-Krebszentrum Comprehensive Cancer Center (RHCCC) and Munich Tumor Center (TZM). For more information, visit: www.sitcancer.org/sitc-meetings/itoc2014.
Thank you to the SITC 2013 Forward Fund Donors!
| Emmanuel T. Akporiaye, PhD Athanasia A. Anagnostou Helen K. Angell, PhD Sandra Aung, PhD Davide Bedognetti, MD, PhD Mark L. Bonyhadi, PhD Michael J. Briskin, PhD Nancy Burns Lisa H. Butterfield, PhD Alessandra Cesano, MD, PhD Martin A. Cheever, MD David Chonzi, MD Joseph I. Clark, MD Brendan D. Curti, MD Sandra Demaria, MD Said Dermime, PhD Peter Ellmark, PhD Alan L. Epstein, MD, PhD James H. Finke, PhD Bernard A. Fox, PhD Gordon J. Freeman, PhD Yang-Xin Fu, MD, PhD Roel Funke, PhD Thomas F. Gajewski, MD, PhD Charlie Garnett Benson, PhD Connie Gee, PhD Jill A. Gershan, PhD John J. Grous, MD George Haas Annika Hakansson, MD, PhD Eric E. Hallowell John P. Hanson, Jr., MD Wael Harb, MD Nancy M. Hardy, MD |
John B. Hawken David R. Huron Annalisa Jenkins, MD Eric Jonasch, MD Jounce Therapeutics Maria Jure-Kunkel, PhD Pawel Kalinski, MD, PhD Adrian A. Kamarasova Howard L. Kaufman, MD, FACS Yutaka Kawakami, MD Jennifer Kay Tibor Keler, PhD Alan J. Korman, PhD Beatrix Kotlan, PhD Solomon Langermann, PhD Howard Liang, PhD Jennifer Litton James N. Lowder, MD Fredrik Lyon Kim A. Margolin, MD Francesco M. Marincola, MD Robert Millman, JD Boris Minev, MD Richard A. Morgan, PhD Tarsem L. Moudgil Nektar Therapeutics Michael Neuberger, MD Hideho Okada, MD, PhD Karolina Palucka, MD, PhD Jungsun Park, PhD Daniel W. Pierce, PhD Karsten A. Pilones, MD, PhD Christian H. Poehlein, MD Mark D. Potter, PhD |
Linda F. Powers Sachin Puri, PhD Laszlo G. Radvanyi, PhD Venky Ramakrishna, PhD Nicholas P. Restifo, MD Pedro J. Romero, MD Gabriela R. Rossi, PhD Donald W. Russel, MD, MS Todd D. Schell, PhD Dolores J. Schendel, PhD Jonathan S. Serody, MD Anil Shanker, PhD Janet C. Siebert, MS Drish Singh Craig L. Slingluff, Jr., MD Paul M. Sondel, MD, PhD Stephen P. Staal, MD Keith E. Steele, DVM, PhD Marius C. Teodorescu, MD, PhD Per thor Straten, PhD Thomas H. Totterman Robert C. Tyler, PhD Viia Valge-Archer, PhD John P. Vasilakos, PhD Luis M. Vence, MS, PhD Antonella Vitiello Susan R. Watson, PhD Brian West Theresa L. Whiteside, PhD Tara Withington, CAE Paul Woodard Michael Yellin, MD Arnold H. Zea, PhD Robert J. Zimmerman, SD |
How Can You Help? Donate to SITC Today!
Or, get your "CURE... Yeah, we said it!" t-shirts!
Now available online here!
Unisex sizes: medium, large, and x-large. 100% cotton.
Price: $25/each; includes shipping to U.S. states and territories.
Contact the SITC office at info@sitcancer.org or 1-414-271-2456 for more information on student pricing, international shipping, and bulk orders.
